Beta3-Adrenoceptor in the eel (Anguilla anguilla) heart: Negative inotropy and NO-cGMP-dependent mechanism

Journal of Experimental Biology

Volumn 209, Issue 24, 2006, Pages 4966-4973

  Imbrogno, S ^a   Angelone, T ^a   Adamo, C ^a   Pulera E ^a   Tota, B ^a   Cerra, M C ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Autocrine paracrine regulation; Catecholamines; cGMP dependent protein kinase; Gi o proteins; Myocardial performance; NOS; Teleost

Indexed keywords

1 (2 ETHYLPHENOXY) 3 (1,2,3,4 TETRAHYDRO 1 NAPHTHYLAMINO) 2 PROPANOL OXALATE; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; ETHANOLAMINE DERIVATIVE; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; NADOLOL; NITRIC OXIDE; PROPANOLAMINE DERIVATIVE;

ANIMAL; ARTICLE; CHEMICAL PHENOMENA; DRUG EFFECT; DRUG POTENTIATION; EEL; HEART; HEART CONTRACTION; IN VITRO STUDY; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANGUILLA; ANIMALS; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DEPRESSION, CHEMICAL; ETHANOLAMINES; GTP-BINDING PROTEINS; HEART; ISOPROTERENOL; MYOCARDIAL CONTRACTION; NADOLOL; NITRIC OXIDE; PROPANOLAMINES; RECEPTORS, ADRENERGIC, BETA-3; SIGNAL TRANSDUCTION;

ANGUILLA ANGUILLA; ANGUILLIDAE; MAMMALIA; TELEOSTEI;

EID: 33846514566     PISSN: 00220949     EISSN: None     Source Type: Journal    
DOI: 10.1242/jeb.02595     Document Type: Article

References (51)

1. Ai, T., Horie, M., Obayashi, K. and Sasayama, S. (1998). Accentuated antagonism by angiotensin II on guinea-pig cardiac L-type Ca-currents enhanced by beta-adrenergic stimulation. Pflug. Arch. 436, 168-174.
2. Angelone, T., Goumon, Y., Cerra, M. C., Metz-boutigue, M. H., Aunis D. and Tota, B. (2006). The emerging cardio-inhibitory role of the Hippocampal Cholinergic Neurostimulating Peptide (HCNP). J. Pharmacol. Exp. Ther. 318, 1-9.
3. 3 and atypical β-adrenoceptors. Med. Res. Rev. 13, 663-729.
4. Arch, J. R. and Wilson, S. (1996). Beta 3-adrenoceptors and the regulation of metabolism in adipose tissues. Biochem. Soc. Trans. 24, 412-418.
5. Balligand, J. L. (2000). The beta 3-adrenoceptor: physiological role and potential therapeutic applications. Acta Clin. Belg. 55, 209-214.
6. 3-adrenoceptor increase in cutaneous blood flow in the dog. J. Pharmacol. Exp. Ther. 268, 1444-1451.
7. Bianchetti, A. and Manara, L. (1990). In vitro inhibition of intestinal motility by phenylethanolamines: evidence of atypical β-adrenoceptors in rat colon. Br. J. Pharmocol. 100, 831-839.
8. Boivin, B., Lavoie, C., Vaniotis, G., Baragli, A., Villeneuve, L-R., Ethier, N., Trieu, P., Allen, B. G. and Hébert, T. E. (2006). Functional β-adrenergic receptor signalling on nuclear membranes in adult rat and mouse ventricular cardiomyocytes. Cardiovasc. Res. 71, 69-78.
9. Brodde, O. E. (1991). Pathophysiology of the beta-adrenoceptor system in chronic heart failure: consequences for treatment with agonists, partial agonists or antagonists? Eur. Heart J. 12F, 54-62.
10. Brodde, O. E., Bruck, H. and Leineweber, K. (2006). Cardiac adrenoceptors: physiological and pathophysiological relevance. J. Pharmacol. Sci. 100, 323-337.
11. 3-adrenergic in human adipose tissue, atrium and skeletal muscle. Int. J. Obes. Relat. Metab. Disord. 10, 1057-1065.
12. Emorine, L. J., Marullo, S., Briend-Sutren, M. M., Patey, G., Tate, K., Delavier-Klutchko, C. and Strosberg, A. D. (1989). Molecular characterization of the human beta 3-adrenergic receptor. Science 245, 1118-1121.
13. Evans, B. A., Papaioannou, M., Bonazzi, V. R. and Summers, R. J. (1996). Expression of beta 3-adrenoceptor mRNA in rat tissues. Br. J. Pharmacol. 117, 210-216.
14. Galitzky, J., Reverte, M., Portillo, M., Carpene, C., Lafontan, M. and Berlan, M. (1993). Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines. Am. J. Physiol. 264, 403-412.
15. Gamperl, A. K., Wilkinson, M. and Boutilier, R. G. (1994). Beta-adrenoreceptors in the trout (Oncorhynchus mykiss) heart: characterization, quantification, and effects of repeated catecholamine exposure. Gen. Comp. Endocrinol. 95, 259-272.
16. 3-adrenoceptor in the human heart. J. Clin. Invest. 98, 556-562.
17. 3- adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J. Clin. Invest. 102, 1377-1384.
18. 3-adrenoceptor agonist. J. Pharmacol. Exp. Ther. 290, 687-693.
19. 3-Adrenoceptors in the cardiovascular system. J. Clin. Invest. 21, 426-430.
20. Gros, J., Manning, B. S., Pietri-Rouxel, F., Guillaume, J. L., Drumare, M. F. and Strosberg, A. D. (1998). Site-directed mutagenesis of the human beta3-adrenoceptor-transmembrane residues involved in ligand binding and signal transduction. Eur. J. Biochem. 251, 590-596.
21. Hare, J. M., Givertz, M. M., Creager, M. A. and Colucci, W. S. (1998). Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: potentiation of beta-adrenergic inotropic responsiveness. Circulation 97, 161-166.
22. Hove-Madsen, L., Mery, P. F., Jurevicius, J., Skeberdis, A. V. and Fishmeister, R. (1996). Regulation of myocardial calcium channels by cyclic AMP metabolism. Basic Res. Cardiol. 91, 1-8.
23. Imbrogno, S., De Iuri, L., Mazza, R. and Tota, B. (2001). Nitric oxide modulates cardiac performance in the heart of Anguilla anguilla. J. Exp. Biol. 204, 1719-1727.
24. Imbrogno, S., Cerra, M. C. and Tota, B. (2003). Angiotensin II-induced inotropism requires an endocardial endothelium-nitric oxide mechanism in the in-vitro heart of Anguilla anguilla. J. Exp. Biol. 206, 2675-2684.
25. Imbrogno, S., Angelone, T., Corti, A., Adamo, C., Helle, K. B. and Tota, B. (2004). Influence of vasostatins, the chromogranin A-derived peptides, on the working heart of the eel (Anguilla anguilla): negative inotropy and mechanism of action. Gen. Comp. Endocrinol. 139, 20-28.
26. Ishikawa, Y. and Homcy, C. J. (1997). The adenylyl cyclases as integrators of transmembrane signal transduction. Circ. Res. 80, 297-304.
27. Kaumann, A. J. (1997). Four beta-adrenoceptor subtypes in the mammalian heart. Trends Pharmacol. Sci. 18, 70-76.
28. Kitamura, T., Onishi, K., Dohi, K., Okinaka, T., Isaka, N. and Nakano, T. (2000).The negative inotropic effect of beta3-adrenoceptor stimulation in the beating guinea pig heart. J. Cardiovasc. Pharmacol. 35, 786-790.
29. Lands, A., Arnold, A., Auliff, J. M. and Luduena, F. (1967). Differentiation of receptor systems activated by simpathomimetic amines. Nature 214, 597-598.
30. Langin, D., Portillo, M., Saulnier-Blache, J. and Lafontan, M. (1991). Coexistences of three β-adrenergic receptors subtypes in white fat cells of various mammalian species. Eur. J. Pharmacol. 199, 291-301.
31. McLaughlin, D. and MacDonald, A. (1990). Evidence for the existence of 'atypical' β-adrenoceptors (β3-adrenoceptors) mediating relaxation in the rat distal colon. Br. J. Pharmacol. 101, 569-574.
32. 2+ current is regulated by cGMP-dependent protein Kinase in mammalian cardiac myocite. Proc. Natl. Acad. Sci. USA 88, 1197-1201.
33. + exchanger in trout erythrocytes is controlled by a novel beta3-AR subtype. Am. J. Physiol. 285, R526-R535.
34. Norman, B. and Learthard, H. (1990). Evidence that an atypical β-adrenoceptor mediates the inhibition of spontaneous rhythmical contractions of rabbit isolated jejunum induced by ritodrine and salbutamol. Br. J. Pharmacol. 101, 27-30.
35. Pelat, M., Verwaerde, P., Galitzky, J., Lafontanm, M., Berlan, M., Senard, J. M. and Montastruc, J. L. (2003). High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs. J. Pharmacol. Exp. Ther. 304, 246-53.
36. 1/2-) and atypical β-adrenoceptor to the stimulation of human white adipocyte lipolysis and right atrial appendace contraction by novel β3-adrenoceptors agonists of differing selectivities. J. Pharmacol. Exp. Ther. 285, 1084-1095.
37. Shen, Y. T., Cervoni, P., Claus, T. and Vatner, S. F. (1996). Differences in beta 3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs. J. Pharmacol. Exp. Ther. 278, 1435-1443.
38. 3-adrenergic receptors. Medicina (Kaunas) 40, 407-412.
39. Sterin-Borda, L., Bernabeo, G., Ganzinelli, S., Joensen, L. and Borda, E. (2006). Role of nitric oxide/cyclic GMP and cyclic AMP in beta3 adrenoceptor-chronotropic response. J. Mol. Cell Cardiol. 40, 580-588.
40. Strosberg, A. D. and Pietri-Rouxel, F. (1996). Function and regulation of the beta 3-adrenoceptor. Trends Pharmacol. Sci. 17, 373-381.
41. 3-adrenergic agonist, does not involve cardiac β-adrenoceptors but reflex mechanism. J. Pharmacol. Exp. Ther. 91, 344-349.
42. Tavernier, G., Toumaniantz, G., Erfanian, M., Heymann, M.-F., Laurent, K., Langin, D. and Gauthier, C. (2003). β3-adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human β3-adrenergic receptor. Cardiovasc. Res. 59, 288-296.
43. Tota, B., Imbrogno, S., Mannarino, C. and Mazza, R. (2004). Vasostatins and negative inotropy uin vertebrate hearts. Curr. Med. Chem. 4, 195-201.
44. Tota, B., Amelio, D., Pellegrino, D., Ip, Y. K. and Cerra, M. C. (2005). NO modulation of myocardial performance in fish hearts. Comp. Biochem. Physiol. 142A, 164-177.
45. Trochu, J. N., Leblais, V., Rautureau, Y., Beverelli, F., Le Marec, H., Berdeaux, A. and Gauthier, C. (1999). Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta. Br. J. Pharmacol. 128, 69-76.
46. 3-adrenoceptor deficiency blocks nitric oxide-dependent inhibition of myocardial contractility. J. Clin. Invest. 106, 697-703.
47. Wheeldon, N. M., McDevitt, D. G. and Lipworth, B. J. (1993). Investigation of putative cardiac beta 3-adrenoceptors in man. Q. J. Med. 86, 255-261.
48. Wheeldon, N. M., McDevitt, D. G. and Lipworth, B. J. (1994). Cardiac effects of the beta 3-adrenoceptor agonist BRL35135 in man. Br. J. Clin. Pharmacol. 37, 363-369.
49. Xiao, R. P., Cheng, H., Zhou, Y. Y., Kuschel, M. and Lakatta, E. G. (1999). Recent advances in cardiac β2-adrenergic signal transduction. Circ Res. 85, 1092-1100.
50. Yoshida, T., Hiraoka, N. and Kondo, M. (1991). Effects of a beta 3-adrenoceptor agonist, BRL 26830A, on insulin and glucagon release in mice. Endocrinol. Jpn. 38, 641-646.
51. 2+ current by beta3-adrenergic stimulation in failing rat heart. J. Pharmacol. Exp. Ther. 315, 1203-1211.